Logo image of IMKTA

INGLES MARKETS INC-CLASS A (IMKTA) Stock Fundamental Analysis

NASDAQ:IMKTA - Nasdaq - US4570301048 - Common Stock - Currency: USD

64.11  -0.17 (-0.26%)

Fundamental Rating

4

Taking everything into account, IMKTA scores 4 out of 10 in our fundamental rating. IMKTA was compared to 40 industry peers in the Consumer Staples Distribution & Retail industry. IMKTA has only an average score on both its financial health and profitability. IMKTA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

IMKTA had positive earnings in the past year.
In the past year IMKTA had a positive cash flow from operations.
In the past 5 years IMKTA has always been profitable.
Each year in the past 5 years IMKTA had a positive operating cash flow.
IMKTA Yearly Net Income VS EBIT VS OCF VS FCFIMKTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.16%, IMKTA is in line with its industry, outperforming 52.50% of the companies in the same industry.
IMKTA has a Return On Equity (5.04%) which is in line with its industry peers.
The Return On Invested Capital of IMKTA (4.58%) is worse than 62.50% of its industry peers.
Industry RankSector Rank
ROA 3.16%
ROE 5.04%
ROIC 4.58%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IMKTA Yearly ROA, ROE, ROICIMKTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

IMKTA's Profit Margin of 1.45% is in line compared to the rest of the industry. IMKTA outperforms 60.00% of its industry peers.
IMKTA's Profit Margin has been stable in the last couple of years.
IMKTA has a Operating Margin of 2.47%. This is comparable to the rest of the industry: IMKTA outperforms 55.00% of its industry peers.
In the last couple of years the Operating Margin of IMKTA has declined.
IMKTA has a Gross Margin (23.55%) which is comparable to the rest of the industry.
IMKTA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.47%
PM (TTM) 1.45%
GM 23.55%
OM growth 3Y-23.38%
OM growth 5Y-2.75%
PM growth 3Y-27.96%
PM growth 5Y-0.74%
GM growth 3Y-3.36%
GM growth 5Y-0.61%
IMKTA Yearly Profit, Operating, Gross MarginsIMKTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IMKTA is destroying value.
IMKTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IMKTA Yearly Shares OutstandingIMKTA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
IMKTA Yearly Total Debt VS Total AssetsIMKTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 4.32 indicates that IMKTA is not in any danger for bankruptcy at the moment.
IMKTA has a Altman-Z score of 4.32. This is comparable to the rest of the industry: IMKTA outperforms 57.50% of its industry peers.
The Debt to FCF ratio of IMKTA is 29.74, which is on the high side as it means it would take IMKTA, 29.74 years of fcf income to pay off all of its debts.
IMKTA has a Debt to FCF ratio of 29.74. This is in the lower half of the industry: IMKTA underperforms 65.00% of its industry peers.
A Debt/Equity ratio of 0.33 indicates that IMKTA is not too dependend on debt financing.
IMKTA has a Debt to Equity ratio (0.33) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 29.74
Altman-Z 4.32
ROIC/WACC0.54
WACC8.49%
IMKTA Yearly LT Debt VS Equity VS FCFIMKTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.3 Liquidity

IMKTA has a Current Ratio of 3.24. This indicates that IMKTA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of IMKTA (3.24) is better than 95.00% of its industry peers.
IMKTA has a Quick Ratio of 1.45. This is a normal value and indicates that IMKTA is financially healthy and should not expect problems in meeting its short term obligations.
IMKTA has a Quick ratio of 1.45. This is amongst the best in the industry. IMKTA outperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 3.24
Quick Ratio 1.45
IMKTA Yearly Current Assets VS Current LiabilitesIMKTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

1

3. Growth

3.1 Past

IMKTA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.38%.
Measured over the past 5 years, IMKTA shows a small growth in Earnings Per Share. The EPS has been growing by 6.63% on average per year.
Looking at the last year, IMKTA shows a decrease in Revenue. The Revenue has decreased by -7.38% in the last year.
Measured over the past years, IMKTA shows a small growth in Revenue. The Revenue has been growing by 6.06% on average per year.
EPS 1Y (TTM)-57.38%
EPS 3Y-24.14%
EPS 5Y6.63%
EPS Q2Q%-61.84%
Revenue 1Y (TTM)-7.38%
Revenue growth 3Y4.18%
Revenue growth 5Y6.06%
Sales Q2Q%-13.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IMKTA Yearly Revenue VS EstimatesIMKTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B
IMKTA Yearly EPS VS EstimatesIMKTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2022 5 10

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.45, IMKTA is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of IMKTA indicates a somewhat cheap valuation: IMKTA is cheaper than 75.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.33. IMKTA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.45
Fwd PE N/A
IMKTA Price Earnings VS Forward Price EarningsIMKTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IMKTA indicates a rather cheap valuation: IMKTA is cheaper than 87.50% of the companies listed in the same industry.
62.50% of the companies in the same industry are cheaper than IMKTA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 68.03
EV/EBITDA 5.75
IMKTA Per share dataIMKTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.33
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

IMKTA has a Yearly Dividend Yield of 1.06%. Purely for dividend investing, there may be better candidates out there.
IMKTA's Dividend Yield is a higher than the industry average which is at 2.32.
Compared to an average S&P500 Dividend Yield of 2.51, IMKTA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.06%

5.2 History

The dividend of IMKTA has a limited annual growth rate of 0.16%.
IMKTA has paid a dividend for at least 10 years, which is a reliable track record.
IMKTA has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.16%
Div Incr Years0
Div Non Decr Years11
IMKTA Yearly Dividends per shareIMKTA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

15.58% of the earnings are spent on dividend by IMKTA. This is a low number and sustainable payout ratio.
IMKTA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP15.58%
EPS Next 2YN/A
EPS Next 3YN/A
IMKTA Yearly Income VS Free CF VS DividendIMKTA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
IMKTA Dividend Payout.IMKTA Dividend Payout, showing the Payout Ratio.IMKTA Dividend Payout.PayoutRetained Earnings

INGLES MARKETS INC-CLASS A

NASDAQ:IMKTA (4/23/2025, 11:26:44 AM)

64.11

-0.17 (-0.26%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)02-06 2025-02-06/bmo
Earnings (Next)05-08 2025-05-08
Inst Owners90.19%
Inst Owner Change0.11%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.22B
Analysts84.44
Price TargetN/A
Short Float %4.98%
Short Ratio6.04
Dividend
Industry RankSector Rank
Dividend Yield 1.06%
Yearly Dividend0.65
Dividend Growth(5Y)0.16%
DP15.58%
Div Incr Years0
Div Non Decr Years11
Ex-Date04-10 2025-04-10 (0.165)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.45
Fwd PE N/A
P/S 0.22
P/FCF 68.03
P/OCF 5.99
P/B 0.78
P/tB 0.78
EV/EBITDA 5.75
EPS(TTM)4.15
EY6.47%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.94
FCFY1.47%
OCF(TTM)10.71
OCFY16.7%
SpS286.82
BVpS82.23
TBVpS82.23
PEG (NY)N/A
PEG (5Y)2.33
Profitability
Industry RankSector Rank
ROA 3.16%
ROE 5.04%
ROCE 6.06%
ROIC 4.58%
ROICexc 5.22%
ROICexgc 5.22%
OM 2.47%
PM (TTM) 1.45%
GM 23.55%
FCFM 0.33%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-23.38%
OM growth 5Y-2.75%
PM growth 3Y-27.96%
PM growth 5Y-0.74%
GM growth 3Y-3.36%
GM growth 5Y-0.61%
F-Score6
Asset Turnover2.18
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 29.74
Debt/EBITDA 1.99
Cap/Depr 149.8%
Cap/Sales 3.4%
Interest Coverage 250
Cash Conversion 78.76%
Profit Quality 22.73%
Current Ratio 3.24
Quick Ratio 1.45
Altman-Z 4.32
F-Score6
WACC8.49%
ROIC/WACC0.54
Cap/Depr(3y)141.52%
Cap/Depr(5y)130.05%
Cap/Sales(3y)2.93%
Cap/Sales(5y)2.85%
Profit Quality(3y)57.86%
Profit Quality(5y)73.44%
High Growth Momentum
Growth
EPS 1Y (TTM)-57.38%
EPS 3Y-24.14%
EPS 5Y6.63%
EPS Q2Q%-61.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.38%
Revenue growth 3Y4.18%
Revenue growth 5Y6.06%
Sales Q2Q%-13.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-46.99%
EBIT growth 3Y-20.18%
EBIT growth 5Y3.15%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-87.59%
FCF growth 3Y-32.19%
FCF growth 5Y0.78%
OCF growth 1Y-32.63%
OCF growth 3Y-5.01%
OCF growth 5Y4.42%